Prolonged bleeding times and bleeding diathesis associated with moxalactam administration.
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000368:Aged; D001424:Bacterial Infections / Q000097:blood / Q000188:drug therapy; D001760:Bleeding Time; D001792:Blood Platelets / Q000187:drug effects*; D002511:Cephalosporins / Q000009:adverse effects*; D002513:Cephamycins / Q000009:adverse effects*; D005260:Female; D006474:Hemorrhagic Disorders / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009070:Moxalactam; D010974:Platelet Aggregation / Q000187:drug effects; D010979:Platelet Function Tests
D002511:Cephalosporins; D002513:Cephamycins; D000244:Adenosine Diphosphate; D009070:Moxalactam